From Surf Wiki (app.surf) — the open knowledge base
5-MeO-DsBT
| Column 1 |
|---|
| 5-MeO-DSBT; 5-Methoxy-N,N-di-sec-butyltryptamine |
| .mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}None |
| IUPAC name |
| N-butan-2-yl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]butan-2-amine |
| 168007543 |
| C19H30N2O |
| 302.462 g·mol−1 |
| Interactive image |
| SMILES |
| CCC(C)N(CCC1=CNC2=C1C=C(C=C2)OC)C(C)CC |
| InChI |
| InChI=1S/C19H30N2O/c1-6-14(3)21(15(4)7-2)11-10-16-13-20-19-9-8-17(22-5)12-18(16)19/h8-9,12-15,20H,6-7,10-11H2,1-5H3Key:KJOIPZZWWSZLRE-UHFFFAOYSA-N |
5-MeO-DsBT, also known as 5-methoxy-N,N-di-sec-butyltryptamine, is a chemical compound and possible psychedelic drug of the tryptamine and 5-methoxytryptamine families related to 5-MeO-DMT. It was briefly mentioned by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved). He described it as being an unknown compound. Relatedly, its route, dose, and duration were not described. 5-MeO-DsBT was first described in the literature by Shulgin in TiHKAL in 1997. It is a skeletal isomer of 5-MeO-DBT. Subsequently, close analogues of 5-MeO-DsBT like 5-MeO-MsBT and 5-MeO-NsBT emerged as novel designer drugs in the early 2020s. 5-MeO-DsBT is not a controlled substance in Canada as of 2025.
-
Substituted tryptamine
-
DsBT and 4-HO-DsBT
-
5-MeO-DSBT - Isomer Design
Ask Mako anything about 5-MeO-DsBT — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report